LUMEBLUE
DEAD

Serial Number

98880974

Owner

Cosmo Technologies Ltd

Attorney

John Pickerill

Filing Date

Dec 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LUMEBLUE Trademark

Serial Number: 98880974

LUMEBLUE is a trademark filed by Cosmo Technologies Ltd on December 2, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Cosmo Technologies Ltd (23 trademarks)

Riverside II
Dublin 2 , IE

Entity Type: 99

Trademark Details

Filing Date

December 2, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations; Medicines for human purposes; Medical reagent; Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing colonoscopy; Diagnostic agents, preparations and substances for medical purposes, namely, the visualization of colonic polyps, adenomas, carcinomas, early stage cancers and other lesions in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), those with previous history of polyps, adenomas, carcinomas, early stage cancers and other lesions, patients with colorectal cancer and patients with relevant family history; Diagnostic reagents and coloring agent for medical and surgical use; Coloring agent for use with imaging medical equipment; Coloring agent for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and polyps, adenomas, carcinomas, early stage cancers and other lesions thereon; pharmaceutical preparations for use in endoscopic or colonoscopic diagnostic evaluation; pharmaceutical preparations for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions during gastrointestinal endoscopic procedures; pharmaceutical preparations for use in gastroenterology for colon and digestive system health and regulation; pharmaceutical preparations for use in endoscopy of the gastrointestinal tract; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal field; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal endoscopy field; pharmaceutical preparations to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; pharmaceutical preparations, namely, coloring agent for use in endoscopic procedures; pharmaceutical compositions, namely, coloring agent for use in endoscopy; pharmaceutical preparations for use as reagents for medical use; pharmaceutical preparations, namely, coloring agent for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue for enhancing visualization during endoscopic procedures; pharmaceutical preparations containing dyes for enhancing visualization during endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue coloring agent for pharmaceutical, medical and surgical purposes; pharmaceutical preparations containing coloring agent dye for pharmaceutical, medical and surgical purposes; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 30, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 30, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2025 CNRT
ASSIGNED TO EXAMINER
May 21, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2024 NWOS
NEW APPLICATION ENTERED
Dec 2, 2024 NWAP